An FDA warning letter to Purolea Cosmetics Lab shows that AI-assisted drafting can support documentation work only when the resulting document is subject to quality-system controls.
Svyatoslav Borshchenko
Advertisement
Svyatoslav Borshchenko is CEO and cofounder, GxPilot.
Articles by Svyatoslav Borshchenko
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
Regeneron's Libtayo Earns CHMP Nod for Expanded EU Dosing
2
Roche, Hansoh Sign Second ADC Pact Covering Preclinical and Roche-Selected Targets
3
Biomarker Testing Gaps Can Stall Targeted Oncology Therapy, BMS’s Dr Pennell Says
4
The BioPharm Brief: New Approval, Pediatric Progress, and Durable Remission
5